Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,686 | -27,991 | -20,222 | -13,890 | -7,777 |
| Depreciation Amortization | 46 | 122 | 84 | 55 | 27 |
| Accounts payable and accrued liabilities | 154 | 2,661 | 2,091 | 1,610 | 642 |
| Other Working Capital | 353 | 8,767 | 6,133 | 6,217 | 2,768 |
| Other Operating Activity | 767 | -2,425 | -2,522 | -2,815 | 143 |
| Operating Cash Flow | $-4,366 | $-18,867 | $-14,436 | $-8,822 | $-4,197 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -250 | -122 | -62 | N/A |
| Investing Cash Flow | $-14 | $-250 | $-122 | $-62 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46 | 2 | 2 | 1 | 1 |
| Common Stock Repurchased | -380 | -157 | -157 | -157 | N/A |
| Financing Cash Flow | $-334 | $-156 | $-156 | $-156 | $1 |
| Exchange Rate Effect | -29 | 19 | -16 | -2 | -5 |
| Beginning Cash Position | 19,636 | 38,889 | 38,889 | 38,889 | 38,889 |
| End Cash Position | 14,892 | 19,636 | 24,159 | 29,847 | 34,689 |
| Net Cash Flow | $-4,744 | $-19,253 | $-14,730 | $-9,042 | $-4,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,366 | -18,867 | -14,436 | -8,822 | -4,197 |
| Capital Expenditure | -14 | -250 | -122 | -62 | N/A |
| Free Cash Flow | -4,380 | -19,117 | -14,559 | -8,884 | -4,197 |